Document is current
Any future updates will be listed below
-
Authors
Seely, Andrew J. E.
Newman, Kimberley
Ramchandani, Rashi
Herry, Christophe
Scales, Nathan
Hudek, Natasha
Brehaut, Jamie
Jones, Daniel
Ramsay, Tim
Barnaby, Doug
Fernando, Shannon
Perry, Jeffrey
Dhanani, Sonny
Burns, Karen E. A.
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research
Physicians' Services Incorporated Foundation
The Ottawa Hospital Academic Medical Organization
University of Ottawa Faculty of Medicine
Ottawa Hospital Departments of Surgery and Critical Care
- License Information
-
More Information
Article History
Received: 23 September 2024
Accepted: 19 October 2024
First Online: 5 December 2024
Declarations
:
: Dr. Andrew Seely is the founder and CEO of Therapeutic Monitoring Systems (TMS) which holds licensing rights to several patents related to variability-derived clinical decision support, where both Andrew Seely and Christophe Herry are patent authors related to this work. Dr. A. Seely discloses the conflict of interest (CoI) in all grants, publications, presentations, and other public communication, and submits a CoI management agreement to Ottawa Hospital Research Institute annually.
